- Home
- CHR vs NXTS Comparison
CHR vs NXTS Comparison
Compare CHR & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHR | NXTS |
|---|---|---|
| Founded | 2016 | 2009 |
| Country | China | Israel |
| Employees | 116 | 9 |
| Industry | EDP Services | Agricultural Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 3.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CHR | NXTS |
|---|---|---|
| Price | $2.07 | $5.83 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 97.2K | 33.8K |
| Earning Date | 03-23-2026 | 05-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.03 | $0.55 |
| 52 Week High | $2.95 | $6.75 |
Technical Indicators
Market Signals| Indicator | CHR | NXTS |
|---|---|---|
| Relative Strength Index (RSI) | 54.69 | 53.40 |
| Support Level | $0.07 | $3.97 |
| Resistance Level | $2.71 | $5.31 |
| Average True Range (ATR) | 0.31 | 0.66 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 46.15 | 41.39 |
Price Performance
Historical ComparisonAbout CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.
About NXTS Nexentis Technologies Inc. Common Stock
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.